Silence Therapeutics PLC SLN Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Silence Therapeutics PLC (SLN)
Silence Therapeutics PLC (SLN) Financials

Silence Therapeutics PLC (SLN)

7.10

0.03

(0.42%)

Closed 28 December 8:00AM

Delayed by 15 minutes

7.10

0.00

( 0.00% )

Pre Market: 11:48PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)
Return on Assets (%)	-14.386	-2.921	-39.217	-46.096	-49.296	-43.268	-39.755	-42.983
Return on Equity (%)	-14.728	-3.038	-42.128	-69.981	-217.212	-448.223	-264.651	-221.19
Return on Invested Capital (%)	-15.663	-12.082	-42.417	-70.137	-201.829	-476.464	-279.862	-240.658
Operating Margin (%)	-1345.714	-23500	N/A	-9359.426	-657.51	-369.295	-270.39	-198.132
Net Profit Margin (%)	-1096.104	-10112.5	N/A	-8025.41	-594.032	-317.439	-231.352	-170.51
Book Value Per Share	0.665	0.633	0.378	0.168	0.011	0.01	0.127	0.075
Earnings Per Share	-0.121	-0.023	-0.259	-0.25	-0.391	-0.439	-0.376	-0.364
Cash Per Share	0.559	0.611	0.302	0.172	0.329	0.819	0.508	0.455
Working Capital Per Share	0.579	0.613	0.361	0.355	0.61	0.793	0.696	0.532
Operating Profit Per Share	0.031	N/A	N/A	0.003	0.027	0.06	0.066	0.131
EBIT Per Share	-0.148	-0.054	-0.289	-0.292	-0.433	-0.511	-0.439	-0.423
EBITDA Per Share	-0.148	-0.054	-0.289	-0.292	-0.433	-0.511	-0.439	-0.423
Free Cash Flow Per Share	-0.118	-0.027	-0.262	-0.256	-0.39	-0.429	-0.376	-0.368

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	69.8M	69.99M	71.07M	78.37M	83.31M	89.79M	107.81M	118.85M

Key Stats and Ratios

Year End 31 December 2023	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023
	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)	GBP (£)
Shares Outstanding	N/A	89.79M	N/A	89.82M	N/A	107.81M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	-167.284	N/A	N/A	N/A	-103.86	N/A
Net Profit Margin (%)	N/A	N/A	-134.289	N/A	N/A	N/A	-89.713	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	332.28M
Price to Earnings Ratio	-2.43
Price to Sales Ratio	4.15
Price to Cash Ratio	1.95
Price to Book Ratio	6.18
Dividend Yield	-

Share Statistics

Shares Outstanding	46.8M
Average Volume (1 week)	0
Average Volume (1 Month)	0
52 Week Change	-
52 Week High	-
52 Week Low	-

More Ratios Coming Soon!

Silence Therapeutics

Gforth 18-1 A2a

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions